Novel Therapeutic Approaches in the Treatment of Multiple Myeloma (Chapel Hill, North Carolina)

Last Modified: May 19, 2002

Share article


Conference Dates: October 24-25, 2002
Conference Location: The School of Medicine of The University of North Carolina at Chapel Hill


Sponsoring Group: The University of North Carolina at Chapel Hill and The Multiple Myeloma Research Foundation

Conference Web Page URL: www.multiplemyeloma.org/events/seminars.html

Topics Covered:

  • Transplants
  • Doxil
  • Thalidomide
  • Current and Emerging Trends
  • Genetics

Conference Objectives: to learn about the latest therapies available in the treatment of Multiple Myeloma

Who Should Attend: Hematologists/oncologists, oncology nurses, patients/families

Conference Agenda: Features: Dr. Gabriel, Dr. VanNess, Dr. Weber, Dr. Decastro, Dr. Richardson

Registration Information: For Professionals: CME office contact is Deedra Donley, 919-962-8886. For Patients: contact the Multiple Myeloma Research Foundation, Sarah Davis, 203-972-1250

Conference Fees: MD $75; RN $50; Patients Free

Continuing Education: Yes

Miscellany: Professional program 7:30am-2pm 10/24, Patient program 10am-3pm 10/25


News
ASH: Novel Drug Beneficial in Multiple Myeloma

Sep 30, 2014 - In patients with relapsed or resistant multiple myeloma who have received up to three prior therapies excluding the first-generation proteasome inhibitor bortezomib, treatment with the second-generation proteasome inhibitor carfilzomib is associated a high response rate and a low incidence of side effects, according to research presented at the annual meeting of the American Society of Hematology, held from Dec. 5 to 8 in New Orleans.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More